A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...

The drug behind Ozempic has been found to restore joint cartilage in osteoarthritis, through a mechanism that works ...

GLP-1 drugs like (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many people with ...

This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Common semaglutide side effects include nausea, vomiting, ...

Researchers analyzing U.S. safety reports say certain medications containing semaglutide may be linked to a rare eye ...

Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...

MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...

Taking semaglutide while breastfeeding isn’t currently advised. More research is needed to know if it’s safe. If you’re taking semaglutide for type 2 diabetes, your healthcare provider can let you ...

MÁLAGA, Spain — An online obesity clinic named Embla was associated with weight loss like that seen in randomized controlled trials (RCTs) of semaglutide, but with less than half of the semaglutide ...

Medical researchers have discovered that semaglutide may reverse the debilitating tissue damage caused by osteoarthritis, the ...